Protecting your business from the impact of drug and alcohol abuse
According to a study conducted by the National Survey on Drug Use and Health (NSDUH), nearly one in 10 full-time workers in the United States has had a recent substance abuse problem.
As an employer, you should implement drug testing in the workplace to protect your business from the impact of drug and alcohol abuse. Conducting drug screening can have positive benefits and is an effective way to ensure a drug-free workplace. IntelliCorp’s drug screenings include:
Whether required prior to employment, or as part of a random drug screening program, urine drug screens help employers maintain a drug-free workforce. A urine test is the most common type of drug screening due to its low cost and fast and painless nature. IntelliCorp’s lab-based urine screens are available with different panels that test for various substances including marijuana, cocaine, amphetamines, opiates, barbiturates, alcohol, and more. The combination of drugs tested can be customized based on an employer’s needs.
Delivering immediate and accurate results, a saliva screen is a low-cost drug screening option. It is often a preferable testing method because specimens are difficult to dilute, substitute, or otherwise tamper with when the test is administered under direct observation. It offers added benefit because it is non-invasive for the applicant or employee. A saliva screen from IntelliCorp is easy to implement and is available as a self-administered kit with non-negative results further tested in a lab.
Random Screening Programs
A random screening program is an effective method that can help an organization maintain a drug-free workforce. Random workplace drug testing is conducted on an unannounced basis and uses a random selection process so any employee can be tested at any time. Whether your organization operates in an industry where it’s required by a regulatory agency, or you simply have a code of conduct that stipulates drug-free employees, IntelliCorp can assist any sized company in creating a successful and compliant random screening program.
Due to constraints from COVID-19 pandemic the DHS has issued deferments regarding some requirements for Form-I9. Read our blog post for more information.
During the worldwide COVID-19 outbreak, it is important for IntelliCorp to let all our clients know we are prepared to operate our business as usual and to continue to support your organizations with background screening services.